PTPase inhibitors and T-cell activators for treating cancer

Details for Australian Patent Application No. 2005304422 (hide)

Owner The Cleveland Clinic Foundation

Inventors Yi, Taolin

Agent Freehills

Pub. Number AU-A-2005304422

PCT Pub. Number WO2006/053162

Priority 10/987,217 11.11.04 US

Filing date 10 November 2005

Wipo publication date 18 May 2006

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/29 (2006.01)

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/053162 Priority application(s): WO2006/053162

5 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005304424-Ophthalmic solution

2005304421-Use of ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure